Prior Ambulatory Mild Coronavirus Disease 2019 Does Not Increase Risk of Acute Mountain Sickness
High Altitude Medicine & Biology · 2023
DOI: 10.1089/ham.2022.0150 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift High Altitude Medicine & Biology, 2023. Verfasst von Elan Small und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Altitude Sickness, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Small, Elan, Caleb Phillips, William Bunzel, Lakota Cleaver, Nishant Joshi, Laurel Gardner, Rony Maharjan, and James Marvel. Prior ambulatory mild coronavirus disease 2019 does not increase risk of acute mountain sickness. High Alt Med Biol. 24:201-208, 2023.
Background
Given its long-term morbidity, understanding how prior coronavirus disease 2019 (COVID-19) may affect acute mountain sickness (AMS) susceptibility is important for preascent risk stratification. The objective of this study was to examine if prior COVID-19 impacts risk of AMS. Materials and Methods: This was a prospective observational study conducted in Lobuje (4,940 m) and Manang (3,519 m), Nepal, from April to May 2022. AMS was defined by the 2018 Lake Louise Questionnaire criteria. COVID-19 severity was defined using the World Health Organization-developed criteria.
Results
In the Lobuje cohort of 2,027, 46.2% of surveyed individuals reported history of COVID-19, with 25.7% AMS point-prevalence. There was no significant relationship between prior ambulatory mild COVID-19 and AMS (p = 0.6) or moderate AMS (p = 1.0). In the Manang cohort of 908, 42.8% reported history of COVID-19, with 14.7% AMS point-prevalence. There was no significant relationship between prior ambulatory mild COVID-19 and AMS (p = 0.3) or moderate AMS (p = 0.4). Average months since COVID-19 was 7.4 (interquartile range [IQR] 3-10) for Lobuje, 6.2 (IQR 3-6) for Manang. Both cohorts rarely exhibited moderate COVID-19 history.
Conclusions
Prior ambulatory mild COVID-19 was not associated with increased risk of AMS and should not preclude high-altitude travel.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
- Department of Computational Science, University of Colorado, Boulder, Colorado, USA.
- Department of Emergency Medicine, University of California San Francisco Fresno, Fresno, California, USA.
- Department of Emergency Medicine, Yale New Haven Health, New Haven, Connecticut, USA.
- Department of General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lalitpur, Nepal.
ORCID-Profile: Elan Small
Zitieren
APA
Small, E., Phillips, C., Bunzel, W., Cleaver, L., Joshi, N., Gardner, L., Maharjan, R., & Marvel, J. (2023). Prior Ambulatory Mild Coronavirus Disease 2019 Does Not Increase Risk of Acute Mountain Sickness. High Altitude Medicine & Biology. https://doi.org/10.1089/ham.2022.0150
Vancouver
Small E, Phillips C, Bunzel W, Cleaver L, Joshi N, Gardner L, et al. Prior Ambulatory Mild Coronavirus Disease 2019 Does Not Increase Risk of Acute Mountain Sickness. High Altitude Medicine & Biology. 2023. doi:10.1089/ham.2022.0150
BibTeX
@article{Small2023,
author = {Small, Elan and Phillips, Caleb and Bunzel, William and Cleaver, Lakota and Joshi, Nishant and Gardner, Laurel and Maharjan, Rony and Marvel, James},
title = {Prior Ambulatory Mild Coronavirus Disease 2019 Does Not Increase Risk of Acute Mountain Sickness},
journal = {High Altitude Medicine & Biology},
year = {2023},
doi = {10.1089/ham.2022.0150}
}
EUVIMED